Becton Dickinson gets its spinoff deal, but the stock is still falling

Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 billion of the proceeds to buy back stock.

Trump’s copper tariff is a first step. Here’s what’s needed now to counter China.

America must control its copper supply — but Washington doesn’t have many chances to get it right.

You can keep buying non-U.S. stocks and ditching the dollar — or you can be smart

Six months of outperformance for international stocks and currencies isn’t a portfolio strategy.

Here’s how the Fed can fight inflation — and shield itself from Trump’s attacks

The Trump administration’s attacks on the Fed highlight the problems with Fed discretion and obscurity.

JPMorgan Chase, Citi and Goldman rallies under scrutiny as earnings updates await

As earnings season kicks off on Tuesday, Wall Street seeks clues on whether big-bank stocks merit more gains after outperformance.

Here’s why this is a golden age for banks — but some of their stocks may be too high

While there are some exceptions among the 20 largest banks, most big bank stocks appear fully valued, based on analysts’ price targets.

Treat your credit score with the respect you would treat a lover

FICO has said it will introduce “buy now, pay later” loan data into its credit-scoring models.

Not just the taco trade — why stocks should be resilient to tariff news, says Morgan Stanley

The U.S. investment bank goes through the reasons why the stock market keeps rising as new and higher tariff levels get announced.

AstraZeneca shares show signs of life after successful trials of hypertension drug

Baxdostat trials showed immense promise for huge available market.

Stocks and U.S. government bonds sell off in tandem Friday as trade jitters cool rally

U.S. stocks and government bonds were swept up in a selloff on Friday, as President Trump’s threats of new tariffs against a host of U.S. trade partners unnerved investors.